Evidence map›Paper›PMID 35893832›Full record

ArticleVaccines2022

Factors Associated with Not Receiving a Booster Dose of COVID-19 Vaccine in Peru.

Guido Bendezu-Quispe, Brenda Caira-Chuquineyra, Daniel Fernandez-Guzman, Diego Urrunaga-Pastor, Percy Herrera-Añazco, Vicente A Benites-Zapata

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. COVID-19 Exposure, Protective Measures, Symptom Assessment, and Risk Perception Among Healthcare Workers in Peru: A Longitudinal Cohort Study (2020-2021).Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Inequalities in COVID-19 vaccination coverage in Peru: An ecological study.Public health in practice (Oxford, England) · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 1 country.

Guido Bendezu-QuispeEscuela de Medicina, Universidad César Vallejo, Trujillo 13001, Peru.
Brenda Caira-ChuquineyraFacultad de Medicina, Universidad Nacional de San Agustín, Arequipa 04001, Peru.
Daniel Fernandez-GuzmanEscuela Profesional de Medicina Humana, Universidad Nacional de San Antonio Abad del Cusco, Cusco 08000, Peru.ORCID 0000-0002-9441-1067
Diego Urrunaga-PastorFacultad de Ciencias de la Salud, Universidad Científica del Sur, Lima 15067, Peru.
Percy Herrera-AñazcoRed Internacional en Salud Colectiva y Salud Intercultural, Mexico City 56690, Mexico.
Vicente A Benites-ZapataRed Internacional en Salud Colectiva y Salud Intercultural, Mexico City 56690, Mexico.
National University of Saint Anthony the Abbot in Cuzco · PEUniversidad César Vallejo · PEUniversidad Científica del Sur · PEUniversidad Nacional de San Agustin de Arequipa · PEUniversidad Privada San Juan Bautista · PEUniversidad San Ignacio de Loyola · PE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To determine the factors associated with not receiving the booster dose for COVID-19 in Peru, a cross-sectional study by secondary analysis of a University of Maryland and Facebook survey database assessing the global impact of COVID-19 was conducted. Data of Peruvian users of this social network over 18 years of age who answered the survey between 13 February 2022 and 14 April 2022 were analyzed. We evaluated the association between sociodemographic characteristics, comorbidities, and history of COVID-19 with having received a booster dose for COVID-19. Crude (cPR) and adjusted (aPR) prevalence ratios with their respective 95% confidence intervals (95%CI) were calculated. A sample of 20,814 adults, 21.5% of whom reported not receiving the booster dose, was analyzed. People under 75 years of age had a higher prevalence of not having received the booster dose. Likewise, having a university education (aPR = 1.03; 95%CI: 1.02-1.05), secondary, or pre-university education (aPR = 1.07; 95%CI: 1.05-1.09), or having a primary level or less (aPR = 1.11; 95%CI: 1.05-1.18), were associated with a higher prevalence of not receiving the booster, compared to individuals with a postgraduate education. Being employed (aPR = 1.01; 95%CI: 1.00-1.02), having had COVID-19 (aPR = 1.03; 95%CI: 1.01-1.04) and living in a town (aPR = 1.05; 95%CI: 1.02-1.07) or in a rural area (aPR = 1.06; 95%CI: 1.03-1.10), compared to living in the city, had a similar association. On the contrary, the female gender was associated with a lower prevalence of not receiving the booster (aPR = 0.97; 95%CI: 0.96-0.99). Sociodemographic characteristics and a history of having had COVID-19 were associated with the probability of not having received the booster dose for COVID-19 in the Peruvian population.

Indexed as

COVID-19COVID-19 vaccine booster shotPeruSARS-CoV-2vaccination refusal

Identifiers

PMID35893832
PMCPMC9330573
OpenAlexW4288178233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.